1. Home
  2. TIRX vs EOLS Comparison

TIRX vs EOLS Comparison

Compare TIRX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TIAN RUIXIANG Holdings Ltd

TIRX

TIAN RUIXIANG Holdings Ltd

N/A

Current Price

$0.66

Market Cap

18.6M

Sector

Finance

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.99

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIRX
EOLS
Founded
2010
2012
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
444.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TIRX
EOLS
Price
$0.66
$6.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.80
AVG Volume (30 Days)
138.8K
1.1M
Earning Date
08-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$285,823,000.00
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$23.27
P/E Ratio
N/A
N/A
Revenue Growth
158.74
15.10
52 Week Low
$0.60
$5.71
52 Week High
$6.45
$17.12

Technical Indicators

Market Signals
Indicator
TIRX
EOLS
Relative Strength Index (RSI) 36.80 52.83
Support Level $0.61 $6.83
Resistance Level $1.10 $7.29
Average True Range (ATR) 0.14 0.25
MACD 0.00 0.01
Stochastic Oscillator 13.90 68.82

Price Performance

Historical Comparison
TIRX
EOLS

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: